Erratum to Commonalities and Challenges in the Development of Clinical Trial Measures in Neurology (Neurotherapeutics, DOI 10.1007/s13311-014-0310-1)

Neurotherapeutics

Volumn 12, Issue 1, 2015, Pages 285-

  Cedarbaum, Jesse M ^a   Stephenson, Diane ^b   Rudick, Richard ^a   Carrillo, Maria C ^c   Stebbins, Glenn ^d   Kerr, Douglas ^a   Heemskerk, Jill ^e   Galpern, Wendy R ^f   Kaufmann, Petra ^g   Cella, David ^h   Isaac, Maria ⁱ   Walton, Marc K ^j  

^a BIOGEN   (United States)

^b CRITICAL PATH INSTITUTE   (United States)

^c ALZHEIMER'S ASSOCIATION   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ EUROPEAN MEDICINES AGENCY   (United Kingdom)

^j CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; DRUG THERAPY; NEUROLOGY; OUTCOME ASSESSMENT;

EID: 84939941427     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-014-0323-9     Document Type: Erratum

References (0)